Medical sales still slow at Toshiba
This article was originally published in Clinica
Sales by Toshiba's (Japan) Information/Communication Systems and Electronic Devices division, which includes medical devices, rose 9.3% to reach ¥,664,627 million ($31,350 million) in the year ended March 31st, 1995. Divisional operating income almost trebled to Yen108,688 million from Yen36,886 million a year earlier. However, the company attributes the rise to personal computers and semiconductors, suggesting that medical sales were as difficult in fiscal 1995 as in fiscal 1994. Group turnover was up 3.5% at Yen4,790,766 million; net income increased 268% to Yen44,693 million.
You may also be interested in...
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”